AstraZeneca and US firm join forces to fight COVID-19
US-based medical enterprise Emergent Biosolutions Inc. enters a pact with AstraZeneca, a leading UK innovative pharmaceutical firm to become manufacturing partners for the potential COVID-19 pandemic vaccine ADZ1222. During the trying and high times for the development of coronavirus vaccine, AstraZeneca has taken the matter in their hands to develop a sufficient amount of vaccines…